These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20078557)

  • 1. Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program.
    Hallander HO; Andersson M; Gustafsson L; Ljungman M; Netterlid E
    APMIS; 2009 Dec; 117(12):912-22. PubMed ID: 20078557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
    Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
    APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
    Dalby T; Petersen JW; Harboe ZB; Krogfelt KA
    J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects.
    Subissi L; Rodeghiero C; Martini H; Litzroth A; Huygen K; Leroux-Roels G; Piérard D; Desombere I
    Clin Microbiol Infect; 2020 May; 26(5):645.e1-645.e8. PubMed ID: 31610300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiology of pertussis in Huzhou: A population-based, cross-sectional study.
    Liu Y; Zhang C; Wang Y; Luo X; Liu G; Zhang Z; Shen J
    PLoS One; 2024; 19(5):e0303508. PubMed ID: 38768133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of Bordetella pertussis specific Immunoglobulin G antibody levels among asymptomatic individuals aged 4 to 24 years: a descriptive cross sectional study from Sri Lanka.
    Sigera S; Perera J; Rasarathinam J; Samaranayake D; Ediriweera D
    BMC Infect Dis; 2016 Dec; 16(1):729. PubMed ID: 27905894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis seroprevalence in korean adolescents and adults using anti-pertussis toxin immunoglobulin G.
    Lee SY; Han SB; Bae EY; Kim JH; Kang JH; Park YJ; Ma SH
    J Korean Med Sci; 2014 May; 29(5):652-6. PubMed ID: 24851020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population.
    Socan M; Prosenc K; Vegnuti M
    Wien Klin Wochenschr; 2006 Jun; 118(11-12):336-40. PubMed ID: 16855922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pertussis seroprevalence and vaccination status in three selected provinces of Turkey].
    Kurtoğlu D; Gözalan A; Cöplü N; Miyamura K; Ishida S; Morita M; Akin L; Esen B
    Mikrobiyol Bul; 2008 Jul; 42(3):389-98. PubMed ID: 18822881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
    Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
    Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia.
    Campbell P; McIntyre P; Quinn H; Hueston L; Gilbert GL; McVernon J
    PLoS One; 2012; 7(4):e35874. PubMed ID: 22558249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination.
    Wanlapakorn N; Ngaovithunvong V; Thongmee T; Vichaiwattana P; Vongpunsawad S; Poovorawan Y
    PLoS One; 2016; 11(2):e0148338. PubMed ID: 26837004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia.
    Kurova N; Timofeeva EV; Guiso N; Macina D
    Vaccine; 2018 Dec; 36(52):7936-7942. PubMed ID: 30448334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Seroepidemiology of pertussis in 10-15 years old healthy children in Isparta province, Turkey].
    Seçkin H; Ormeci AR; Sandal G; Kaya S
    Mikrobiyol Bul; 2013 Jul; 47(3):507-13. PubMed ID: 23971928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children.
    Hallander HO; Ljungman M; Storsaeter J; Gustafsson L
    APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Seroprevalence of pertussis toxin antibody in Manisa province of Turkey, after six years implementation of acellular pertussis vaccine].
    Özbek ÖA; Öktem İMA; Hekimoğlu CH; Sekreter Ö; Emek M; Atasoylu G; Açıkgöz A; Demirpençe N; Ceylan A; Baykal ES; Ünal B
    Mikrobiyol Bul; 2018 Apr; 52(2):180-189. PubMed ID: 29933735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of anti-pertussis toxin ELISA and agglutination assays to assess immune responses to pertussis.
    Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
    Infect Dis (Lond); 2017 Aug; 49(8):594-600. PubMed ID: 28335677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibody to Bordetella pertussis in neonates and prevalence of recent pertussis infection in pregnant women in Catalonia (Spain) in 2003 and 2013.
    Plans P; Álvarez E; de Ory F; Campins M; Payà T; Balfagón P; Godoy P; Caylà J; Carreras R; Cabero L; Domínguez A;
    Pediatr Infect Dis J; 2014 Nov; 33(11):1114-8. PubMed ID: 24871642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A General Lack of IgG Against Pertussis Toxin in Chinese Pregnant Women and Newborns.
    Meng QH; Luo J; Yang F; Shen YJ; Li L; Li LJ; Shi W; Wang YJ; Yao KH
    Pediatr Infect Dis J; 2018 Sep; 37(9):934-938. PubMed ID: 29406469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of pertussis in China: need to improve vaccination strategies.
    Xu Y; Wang L; Xu J; Wang X; Wei C; Luo P; Ma X; Hou Q; Wang J
    Hum Vaccin Immunother; 2014; 10(1):192-8. PubMed ID: 24018405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.